source
- ResMed issues correction for Astral ventilators due to electrical component failure riskResMed has released a correction for certain Astral ventilators after identifying a faulty electrical component that could interrupt therapy and cause serious injury or death. The FDA classifies t…
- Madrigal spends $255 million on multiple MASH drug deals to complement RezdiffraMadrigal Pharmaceuticals is expanding its MASH pipeline by acquiring several assets that could be used alongside its lead candidate, Rezdiffra. In early 2026 the company paid $50 million to Pfizer…